POINTER trial, published in JAMA in July 2025, provides the most rigorous current answer
Surprisingly, the study found the opposite: patients exposed to GLP-1 receptor agonists had a substantially higher risk of developing wet AMD and were diagnosed sooner than comparable patients not taking these medications
They also provided blood samples before and after the study to measure their liver function
Thank you very much granny 2024 this is what I need my friend to see
As such, Raorane said the company would be repurposing the Glutone range of products by highlighting how the antioxidant activities of glutathione could have both skin lightening and antioxidant benefits for immune health
She turned to Zealthy back in 2024, when her doctor refused to prescribe semaglutide to her because the treatment was, in Harriss words, still newish. Her insurance wouldnt cover any weight-loss drugs